IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 49 filers reported holding IMMUNE DESIGN CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $208,000 | +118.9% | 35,567 | -51.2% | 0.00% | – |
| Q4 2018 | $95,000 | -57.0% | 72,909 | +13.7% | 0.00% | – |
| Q3 2018 | $221,000 | -7.9% | 64,144 | +21.5% | 0.00% | – |
| Q2 2018 | $240,000 | +287.1% | 52,776 | +181.9% | 0.00% | – |
| Q1 2018 | $62,000 | -11.4% | 18,722 | +4.7% | 0.00% | – |
| Q4 2017 | $70,000 | -75.9% | 17,882 | -40.1% | 0.00% | – |
| Q2 2017 | $291,000 | +148.7% | 29,878 | +94.3% | 0.00% | – |
| Q3 2016 | $117,000 | -69.1% | 15,378 | -50.4% | 0.00% | – |
| Q3 2015 | $379,000 | -65.3% | 31,027 | -41.3% | 0.00% | – |
| Q2 2015 | $1,092,000 | +290.0% | 52,870 | +299.2% | 0.00% | – |
| Q1 2015 | $280,000 | -75.2% | 13,244 | -63.9% | 0.00% | – |
| Q4 2014 | $1,128,000 | +122.5% | 36,652 | +27.7% | 0.00% | – |
| Q3 2014 | $507,000 | – | 28,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |